BioLife Solutions, Inc.
BLFS
$20.12
-$0.55-2.66%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 102.19M | 92.54M | 85.86M | 80.16M | 74.65M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 102.19M | 92.54M | 85.86M | 80.16M | 74.65M |
| Cost of Revenue | 36.54M | 31.74M | 28.99M | 26.51M | 24.55M |
| Gross Profit | 65.66M | 60.80M | 56.87M | 53.64M | 50.10M |
| SG&A Expenses | 56.29M | 55.98M | 53.21M | 50.88M | 49.56M |
| Depreciation & Amortization | 2.18M | 318.00K | 302.00K | 277.00K | 263.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 104.70M | 94.42M | 88.08M | 82.56M | 79.12M |
| Operating Income | -2.51M | -1.89M | -2.22M | -2.40M | -4.48M |
| Income Before Tax | -13.51M | -14.97M | -16.23M | -6.08M | -8.82M |
| Income Tax Expenses | 49.00K | 246.00K | 84.00K | -41.00K | -38.00K |
| Earnings from Continuing Operations | -13.56 | -15.22 | -16.31 | -6.03 | -8.79 |
| Earnings from Discontinued Operations | 8.96M | 12.01M | 10.78M | -4.38M | -11.40M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.60M | -3.21M | -5.53M | -10.41M | -20.18M |
| EBIT | -2.51M | -1.89M | -2.22M | -2.40M | -4.48M |
| EBITDA | 2.18M | 3.92M | 4.57M | 5.37M | 4.18M |
| EPS Basic | -0.10 | -0.06 | -0.11 | -0.23 | -0.45 |
| Normalized Basic EPS | 0.03 | 0.01 | -0.01 | -0.03 | -0.07 |
| EPS Diluted | -0.11 | -0.07 | -0.12 | -0.24 | -0.45 |
| Normalized Diluted EPS | 0.03 | 0.01 | -0.01 | -0.03 | -0.07 |
| Average Basic Shares Outstanding | 191.00M | 189.51M | 187.76M | 185.96M | 184.26M |
| Average Diluted Shares Outstanding | 192.67M | 191.69M | 189.14M | 187.35M | 185.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |